Chasing Profits: The Drug Companies’ Ethical Dilemma
Pharmaceutical companies are often seen exploiting legal loopholes to increase their profits at the expense of patient safety. The case involving Gilead Sciences highlights a troubling delay in releasing a safer drug, raising important questions about the impact of corporate decisions on public health. Of particular concern is a tactic known as “product hopping” which … Read more
